ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
NASDAQ:EPIX
Price:
6.62 USD
2.95%
Updated:
May 2, 2024
ESSA Pharma Inc
Selling, General & Administrative
|
ESSA Pharma Inc
Selling, General & Administrative Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ESSA Pharma Inc
NASDAQ:EPIX
|
Selling, General & Administrative
-$11m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Selling, General & Administrative
-$70.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Selling, General & Administrative
-$33.6m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Selling, General & Administrative
-$31.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Selling, General & Administrative
-$195m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-70%
|
CAGR 10-Years
-56%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Selling, General & Administrative
-CA$11.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
0%
|
See Also
What is ESSA Pharma Inc's Selling, General & Administrative?
Selling, General & Administrative
-11m
USD
-11m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Selling, General & Administrative amounts to -11m USD.
What is ESSA Pharma Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-12%
-12%
Over the last year, the Selling, General & Administrative growth was 9%. The average annual Selling, General & Administrative growth rates for ESSA Pharma Inc have been 1% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
